ABUS vs MS
Arbutus Biopharma Corp (ABUS) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
MS does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ABUS and MS stock pages for the full models.
Not investment advice.